Humacyte, Inc. - *W EXP 08/27/202 (HUMAW)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / *W EXP 08/27/202
Number of holders
11
Total Shares
800K
Shares change
-66.6K
Total reported value, excl. options
$333K
Value change
-$33K
Put/Call ratio
0
Number of buys
3
Number of sells
-4
Price
$0.42
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.